カテゴリ： , , MarketLine

United Bank Of India

◆英語タイトル：United Bank Of India - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY3139
◆発行会社（調査会社）：MarketLine
◆発行日：2019
◆ページ数：39
◆レポート言語：
◆レポート形式：PDF
◆納品方法：E
◆対象地域：
◆産業分野：Financial Services
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site LicenseUSD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide LicenseUSD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

United Bank Of India – Strategy, SWOT and Corporate Finance Report
Summary

United Bank Of India – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

United Bank of India (UBI) offers a wide range of retail, commercial, and international banking solutions to individuals, SMEs, and corporates. Its offerings include deposit accounts, mortgages, non-resident Indian (NRI) accounts and deposits, loans against deposits, debenture trustee, mutual funds, insurances, term loans, smart loans, personal loans, automobile financing, debit and credit cards, investment plans, remittance services, and lockers. The bank provides working capital finance, international banking solutions, corporate and export credit, cash management services, public issues, and collection and payment services. The bank operates through regional offices, branches, ATMs, and extension counters in India. It also has representative offices located in Bangladesh and Myanmar. UBI is headquartered in Kolkata, India.

Scope

- Detailed information on United Bank Of India required for business and competitor intelligence needs
- A study of the major internal and external factors affecting United Bank Of India in the form of a SWOT analysis
- An in-depth view of the business model of United Bank Of India including a breakdown and examination of key business segments
- Intelligence on United Bank Of India’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about United Bank Of India, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of United Bank Of India and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess United Bank Of India as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on United Bank Of India’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
United Bank of India: Company Overview
United Bank of India: Overview and Key Facts
United Bank of India: Overview
United Bank of India: Key Facts
United Bank of India: Key Employees
United Bank of India: Key Employee Biographies
United Bank of India: Major Products and Services
United Bank of India: Company History
United Bank of India: Management Statement
United Bank of India: Locations and Subsidiaries
United Bank of India: Key Competitors
United Bank of India: Company Analysis
United Bank of India: Business Description
United Bank of India: SWOT Analysis
United Bank of India: SWOT Overview
United Bank of India: Strengths
United Bank of India: Weaknesses
United Bank of India: Opportunities
United Bank of India: Threats
United Bank of India: Corporate Financial Deals Activity
United Bank of India: Financial Deals Overview
United Bank of India: Top Deals 2015 – 2019YTD*
United Bank of India: Mergers and Acquisitions
United Bank of India: Capital Raising
United Bank of India: Recent Developments
United Bank of India: News and Events Summary
United Bank of India: Business Expansion
United Bank of India: Corporate Governance
United Bank of India: Financial Performance
United Bank of India: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: United Bank of India: Key Facts
Table 2: United Bank of India: Key Employees
Table 3: United Bank of India: Company History
Table 4: United Bank of India: Locations and Subsidiaries
Table 5: United Bank of India: Key Competitors
Table 6: United Bank of India: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: United Bank of India: Top Deals 2015 - 2019YTD*
Table 8: United Bank of India: M&A Volume and Value Trend (2015 - YTD*2019)
Table 9: United Bank of India: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 10: United Bank of India: Capital Raising by Deal Type (2015 - YTD*2019)
Table 11: United Bank of India: News and Events Summary
Table 12: United Bank of India: Business Expansion
Table 13: United Bank of India: Corporate Governance
Table 14: United Bank of India: Financial Performance
Table 15: United Bank of India: Strategy and Operations

★海外企業調査レポート[United Bank Of India]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Oragenics Inc (OGEN)-製薬・医療分野：企業M&A・提携分析
    Summary Oragenics Inc (Oragenics) is a biopharmaceutical company that focuses on the development and commercialization of novel antibiotics against infectious disease and develops treatments for oral mucositis. The company develops a new class of potent gram-positive antibiotics which are called Lan …
  • Edelweiss Financial Services Ltd：企業のM&A・事業提携・投資動向
    Edelweiss Financial Services Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Edelweiss Financial Services Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Adverum Biotechnologies Inc (ADVM)：製薬・医療：M&Aディール及び事業提携情報
    Summary Adverum Biotechnologies Inc (Adverum), formerly Avalanche Biotechnologies Inc, is a clinical-stage gene therapy provider. The company’s product pipeline includes AVDM-053, ADVM-022 and AVA-311. Its products are used for treatment of antitrypsin deficiency, hereditary angioedema, wet age-rela …
  • First Interstate BancSystem, Inc.：企業の戦略・SWOT・財務情報
    First Interstate BancSystem, Inc. - Strategy, SWOT and Corporate Finance Report Summary First Interstate BancSystem, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Grupo Ferrer Internacional SA：企業の戦略・SWOT・財務情報
    Grupo Ferrer Internacional SA - Strategy, SWOT and Corporate Finance Report Summary Grupo Ferrer Internacional SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Intra-Cellular Therapies Inc (ITCI)：企業の財務・戦略的SWOT分析
    Summary Intra-Cellular Therapies Inc (ITI) is a novel drug manufacturer. The company offers product platform such as ITCI Pipeline that includes lumateperone, ITI-007 platform, PDE inhibitor platform and drug discovery platform. The company’s lead product candidate ITI-007-lumateperone is to treat s …
  • Clark Public Utilities：企業の戦略的SWOT分析
    Clark Public Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sociedad General de Aguas de Barcelona SA：企業の戦略的SWOT分析
    Sociedad General de Aguas de Barcelona SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Entergy Corporation (ETR)：電力：M&Aディール及び事業提携情報
    Summary Entergy Corporation (Entergy) is an integrated energy company that generates, transmits, distributes and sells electricity. The company generates electricity from various sources including natural gas, nuclear, coal, hydroelectric, solar and oil based power plants. Entergy also operates natu …
  • NeuroBo Pharmaceuticals Inc (NRBO)：企業の財務・戦略的SWOT分析
    NeuroBo Pharmaceuticals Inc (NRBO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Reichhold LLC 2：企業の戦略的SWOT分析
    Reichhold LLC 2 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Newfield Exploration Company (NFX)-石油・ガス分野：企業M&A・提携分析
    Summary Newfield Exploration Company (Newfield) is an independent upstream company. The company focuses on onshore large scale, liquids-rich resource plays. Its domestic assets are in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota and the Uinta Basin of Utah. The com …
  • Autodesk Inc：企業のM&A・事業提携・投資動向
    Autodesk Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Autodesk Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Panacea Pharmaceuticals Inc-製薬・医療分野：企業M&A・提携分析
    Summary Panacea Pharmaceuticals Inc (Panacea) is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutic and diagnostic products for the treatment of cancer and central nervous system diseases. The company’s pipeline products include PAN-301-1, a human aspa …
  • Bottomline Technologies (de), Inc. (EPAY)：企業の財務・戦略的SWOT分析
    Bottomline Technologies (de), Inc. (EPAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Mercy Health：企業の戦略的SWOT分析
    Mercy Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Pfizer Inc (PFE)：企業の財務・戦略的SWOT分析
    Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • KARL STORZ SE & Co KG：企業の戦略的SWOT分析
    KARL STORZ SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Publicis Groupe SA (PUB)：企業の財務・戦略的SWOT分析
    Publicis Groupe SA (PUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • C-Rad AB (CRAD B)：医療機器：M&Aディール及び事業提携情報
    Summary C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets advanced radiation therapy equipments. The company offers products and solutions for patient positioning, tumor localization, and radiation treatment systems. Its products include sentinel 4DCT, catalyst HD, …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆